|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| NET REVENUES: | |||||
| Revenue | |||||
| Products and services | |||||
| Other | |||||
| Total revenue | |||||
| COST OF PRODUCTS AND SERVICES SOLD | |||||
| Gross profit | |||||
| OPERATING EXPENSES: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Loss on impairments | |||||
| Change in the estimated fair value of acquisition-related contingent consideration | |||||
| Gain on sale of assets | |||||
| Total operating expenses | |||||
| Operating (loss) income | |||||
| OTHER INCOME | |||||
| (Loss) income before income taxes and equity investment | |||||
| INCOME TAX EXPENSE | |||||
| (LOSS) INCOME BEFORE EQUITY INVESTMENT | |||||
| LOSS ON EQUITY INVESTMENT | |||||
| NET (LOSS) INCOME | |||||
| (LOSS) INCOME PER SHARE: | |||||
| Basic earnings per share (in US dollars per share) | |||||
| Diluted earnings per share (in US dollars per share) | |||||
| SHARES USED IN COMPUTING (LOSS) INCOME PER SHARE: | |||||
| Basic weighted average number of shares outstanding (in shares) | |||||
| Diluted weighted average number of shares outstanding (in shares) |
Loading...
